4-phenylbutyric acid has been researched along with Amyloidosis in 1 studies
4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lozano-Cruz, T | 1 |
Alcarraz-Vizán, G | 1 |
de la Mata, FJ | 1 |
de Pablo, S | 1 |
Ortega, P | 1 |
Duarte, Y | 1 |
Bravo-Moraga, F | 1 |
González-Nilo, FD | 1 |
Novials, A | 1 |
Gómez, R | 1 |
1 other study available for 4-phenylbutyric acid and Amyloidosis
Article | Year |
---|---|
Cationic Carbosilane Dendritic Systems as Promising Anti-Amyloid Agents in Type 2 Diabetes.
Topics: Amyloidosis; Animals; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Islets of Langer | 2020 |